Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.60 |
| ▸ | CRHBP | P24387 | 1/20 | 0.59 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.58 |
| ▸ | MGLL | Q99685 | 1/20 | 0.57 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | DRD2 | P14416 | 1/20 | 0.55 |
| ▸ | DRD4 | P21917 | 1/20 | 0.55 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9308071 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL9232088 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL5052431 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL3332201 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL51004 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL8410318 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL5387345 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL5049067 | 1.00 | MAPT (0.62) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL1240044 | 0.98 | MAPT (0.63) | MAPTL3MBTL1NPC1RAB9AHRH3 | |
| SCHEMBL25232552 | 0.95 | MAPT (0.65) | MAPTL3MBTL1NPC1RAB9AHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998010852-A1 | SUPPORTED LIQUID MEMBRANE SEPARATION | COMMODORE SEPARATION TECHNOLOGIES, INC. (US) | 1998-03-19 | — | — | WO | claimed |
| US-20250034139-A1 | AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY | PHARMA CINQ, LLC | 2025-01-30 | — | — | US | disclosed |
| US-12139483-B2 | Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity | PHARMA CINQ, LLC (US) | 2024-11-12 | — | — | US | disclosed |
| CN-111562729-B | Light-responsive low-molecular material, adhesive, toner, and image forming method | 柯尼卡美能达株式会社 | 2024-04-05 | — | — | CN | disclosed |
| CN-111580360-B | Toner for developing electrostatic image and image forming method | 柯尼卡美能达株式会社 | 2023-09-22 | — | — | CN | disclosed |
| US-11702398-B2 | Photoresponsive low-molecular weight material, adhesive, toner, and image forming method | Konica Minolta, Inc. (JP) | 2023-07-18 | — | — | US | disclosed |
| US-20210163476-A1 | IMIDAZOQUINOLYL COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY | PHARMA CINQ, LLC | 2021-06-03 | — | — | US | disclosed |
| US-10934284-B2 | Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity | WELLSTAT THERAPEUTICS CORPORATION (US) | 2021-03-02 | — | — | US | disclosed |
| CN-108250142-B | Amine compounds having anti-inflammatory, antifungal, antiparasitic and anticancer activity | 维尔斯达医疗公司 | 2021-01-26 | — | — | CN | disclosed |
| CN-111580360-A | Toner for developing electrostatic image and image forming method | 柯尼卡美能达株式会社 | 2020-08-25 | — | — | CN | disclosed |
| EP-0907647-A1 | CROWN CALIX 4]ARENES, METHOD OF PREPARATION AND USE FOR SELECTIVE EXTRACTION OF CAESIUM | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1999-04-14 | — | — | EP | disclosed |
| US-5866087-A | FROM AQUEOUS SOLUTIONS OF WASTE FUELS | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1999-02-02 | — | — | US | disclosed |
| WO-1998039321-A1 | CROWN CALIX[4]ARENES, METHOD OF PREPARATION AND USE FOR SELECTIVE EXTRACTION OF CAESIUM | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1998-09-11 | — | — | WO | disclosed |
| EP-0335274-B1 | Formation of nitrophenyl ethers from polyols and nitroanisoles | DOW CHEMICAL CO (US) | 1996-03-13 | — | — | EP | disclosed |
| EP-0695304-A1 | CALIX 4 ARENE CROWN ETHERS, METHOD FOR PREPARING SAME, AND USE THEREOF FOR THE SELECTIVE EXTRACTION OF CAESIUM AND ACTINIDES | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 1996-02-07 | — | — | EP | disclosed |
| EP-0670840-A1 | BIS-CROWN CALIX 4]ARENES, METHOD FOR PREPARING SAME AND USE THEREOF FOR SELECTIVELY RECOVERING CESIUM AND ACTINIDES. | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 1995-09-13 | — | — | EP | disclosed |
| WO-1994024138-A1 | CALIX|4|ARENE CROWN ETHERS, METHOD FOR PREPARING SAME, AND USE THEREOF FOR THE SELECTIVE EXTRACTION OF CAESIUM AND ACTINIDES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1994-10-27 | — | — | WO | disclosed |
| WO-1994012502-A1 | BIS-CROWN CALIX[4]ARENES, METHOD FOR PREPARING SAME AND USE THEREOF FOR SELECTIVELY RECOVERING CESIUM AND ACTINIDES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1994-06-09 | — | — | WO | disclosed |
| US-4960950-A | Formation of nitrophenyl ethers from polyols and nitroanisoles | THE DOW CHEMICAL COMPANY (US) | 1990-10-02 | — | — | US | disclosed |
| EP-0335274-A2 | Formation of nitrophenyl ethers from polyols and nitroanisoles | THE DOW CHEMICAL COMPANY (US) | 1989-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163476-A1 | IMIDAZOQUINOLYL COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY | NOD1, NLRP3, AADAC | MAPT 2848/4885L3MBTL1 1523/4885NPC1 2710/4885 |
| US-11702398-B2 | Photoresponsive low-molecular weight material, adhesive, toner, and image forming method | ICAM1, CDH1, ACTR5 | MAPT 209/4885L3MBTL1 3156/4885NPC1 4771/4885 |
| US-20250034139-A1 | AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY | AADAC, CASP1, AAAS | MAPT 1131/4885L3MBTL1 1868/4885NPC1 1958/4885 |
| US-12139483-B2 | Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity | NOD1, NLRP3, AADAC | MAPT 2848/4885L3MBTL1 1523/4885NPC1 2710/4885 |
| US-10934284-B2 | Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity | AAAS, AADAC, NFKBIA | MAPT 2661/4885L3MBTL1 2833/4885NPC1 3086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.